Clinical Trial Update: Assessment of Dutasteride Topical Solution in Male Androgenetic Alopecia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial assessing a topical dutasteride formulation for male androgenetic alopecia; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• Dutasteride topical solution (dutasteride)

Snippet

Sponsor: Moogene Medi Co., Ltd | Conditions: Androgenetic Alopecia | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING